Cardiovascular Associates of America

What Cardiovascular Associates of America does

Cardiovascular Associates of America (CVAUSA) is a physician-led, Webster Equity Partners-backed cardiovascular care platform formed in 2020 and headquartered in Orlando, Florida. The company acquires and partners with independent cardiology practices, providing growth capital, administrative support and operational resources while partner physicians retain clinical and operational autonomy. The platform spans 460+ cardiovascular physicians and advanced practice providers across 100+ clinic locations in 8 states, with 10 ambulatory surgery centers and 15 office-based labs, serving approximately 1.3 million active patients annually. CVAUSA reports 557+ physicians and APPs across 160+ locations in 8 states in materials describing its partner network, and 2,200+ employees across the enterprise.

CVAUSA's core operating units include the Novocardia division for value-based care contracting (with payer partnerships including Humana for Medicare Advantage members, InnovaCare Health, and Prospect Medical Holdings/CharterCare), the Novolink Health subsidiary (formerly Duxlink Health) for high-risk home-based cardiac care using a proprietary patented model, and the CVAUSA Research Network that makes 1M+ trial-eligible patients across 155 locations available to clinical trial sponsors. Subsidiary practices — including Shore Heart Group (New Jersey), Atria Heart (Arizona), and Heart and Vascular Center of Arizona — operate under retained local brands.

The technology stack integrates vendor partner solutions rather than proprietary AI models: Heartflow One for AI-driven non-invasive coronary artery disease detection via CCTA; Clinii for AI-enabled virtual care management of heart failure and hypertension; HybridChart for mobile rounding and revenue cycle data capture; ROMTech's PortableConnect for home-based cardiac rehabilitation with real-time cardiac telemetry; and Ascertain for agentic AI automation of prior authorizations across the 460+ physician network. The business model combines traditional practice management fees, value-based care contracting through Novocardia, technology integration revenues, and shared-services scale across acquired practices. Distribution is direct via a CEO-led enterprise sales motion that begins with no-obligation meetings with independent cardiology practice owners and progresses through NDA, practice evaluation and competitive acquisition offers.

Name

Cardiovascular Associates of America

Legal name

CVAUSA Management LLC

Website

https://cvausa.com

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

101–250 employees

Short description

Cardiovascular Associates of America (CVAUSA) is a Webster Equity Partners-backed, physician-led platform that provides growth capital, administrative support and value-based care enablement to independent cardiology practices across 8 states, serving 1.3 million patients through 460+ physicians at 100+ clinic locations.

Ownership category

akta.pro rank

Product category

Cardiology Practice Management Services

NAICS

Offices of Physicians (except Mental Health Specialists) (621111), Offices of Physicians (62111), Diagnostic Imaging Centers (621512)

SIC

Services-Specialty Outpatient Facilities, Nec (8093), Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

General Cardiology (Consultative) (HLAKABAA)

akta.pro secondary industries

Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity) (HLALAFAA), Ambulatory Cardiology Diagnostic & Procedure Centers (Non-hospital-based) (HLAFABAK), Cardiac Rehabilitation & Secondary Prevention (HLAKABAJ)

Keywords

• Cardiology practice management
• Physician practice partnerships
• Value-based cardiovascular care
• Cardiology network services
• Healthcare private equity

Headquarters

HQ city

Celebration

HQ country

Australia

HQ region

Oceania

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Marketing or Sales, Technology or R&D

Revenue model

1. Physician Practice Management: CVAUSA provides growth capital and administrative support to partner cardiology practices while maintaining physician autonomy. Revenue is generated through operational support, shared best practices, and value-based care enablement.
2. Value-Based Care Contracting: Development and implementation of innovative, cost-effective care models and value-based contracting strategies through the Novocardia Care Solutions division.
3. Technology Integration Services: Implementation of advanced diagnostic technologies like Heartflow AI across the clinical network, providing enhanced cardiovascular diagnostics.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels6 records

Core offering

Cardiovascular Associates of America partners with independent cardiology practices by providing growth capital, administrative and operational support, value-based care enablement, and integrated technology resources, while preserving clinical and operational autonomy for partner physicians. The platform operates across 8 states with 160+ clinic locations, 557+ physicians and APPs, and more than 1 million active patients, delivering services through divisions such as Novocardia (value-based care), Novolink Health (high-risk home care), and the CVAUSA Research Network (clinical trials).

Product overview

Cardiovascular Associates of America (CVAUSA) operates as a physician-led national cardiovascular platform that provides capital investment, administrative support, operational guidance, and value-based care enablement to independent cardiology practices. The platform maintains a modular architecture combining its core physician practice management model with multiple integrated technology solutions including Clinii for virtual care management, HybridChart for mobile rounding, Heartflow One for AI diagnostics, Ascertain for AI workflow automation, and ROMTherapy for home-based cardiac rehabilitation. The Novocardia division handles value-based care operations while Novolink Health provides high-risk home care services. CVAUSA's research network supports clinical trials across its 160+ clinic locations in 8 states serving over 1 million patients annually.

Differentiator

Problem solved

Functional benefit

Brands

• Novocardia: Value-based care division of CVAUSA focused on developing and implementing innovative, cost-effective care models and value-based contracting strategies
• Novocardia Care Solutions
• Luminaries in Cardiology Award

Products and services

• CVAUSA Platform A physician-led national cardiovascular platform that partners with independent cardiology practices to provide growth capital, administrative support, and operational guidance. Practices maintain clinical and operational autonomy and ownership of local operations while benefiting from network-level resources across 160+ clinic locations in 8 states.
• Novocardia Value-Based Care Division Value-based care division of CVAUSA that develops and implements innovative, cost-effective care models and value-based contracting strategies for cardiovascular care, including partnerships with payers such as Humana to deliver coordinated Medicare Advantage cardiology care.
• Novolink Health High-Risk Care at Home High-risk care at home service organization providing an alternative to traditional hospital-based care for high-risk, high-cost, complex cardiovascular patients through proprietary remote monitoring technology, specialized caregiver training programs, and home-based diagnostic services.
• CVAUSA Research Network Clinical research division offering patients access to cardiovascular clinical trials across 155 research locations in 25 practices in 8 states, with 1.0M+ unique patients available for clinical trials annually. Engages with research sponsors and providers for cardiovascular clinical trial delivery.
• Atria Heart Cardiovascular Care Cardiovascular care and treatment services delivered through Atria Heart centers serving the Scottsdale/Phoenix metropolitan area, providing evidence-based cardiovascular care to patients as part of the CVAUSA network.

Quantifiable outcome

• Over 400,000 patients served after Novocardia merger
• +2 more outcomes

Named customers8 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration5 records

AI capability10 records

Feature6 records

Partnerships

Ten partnerships are on record, tiered core.

• Minority Health InstitutecoreStrategic or Co-development Partner · 28 April 2026Strategic partnership aimed at improving access to cardiovascular care and advancing initiatives to reduce healthcare disparities and inequities across diverse populations. Led by Dr. Richard Allen Williams as ESG Advisor.
• HeartflowcoreTechnology or Integration · 24 March 2026Implementation of Heartflow's AI-powered diagnostic technology (Heartflow One) across CVAUSA's clinical network. Platform provides non-invasive coronary artery disease detection through personalized 3D modeling and plaque analysis using CCTA imaging.
• HumanacoreStrategic or Co-development Partner · 4 March 2026Humana expands value-based cardiology partnerships with Novocardia Care Solutions, increasing access to coordinated cardiovascular care for Medicare Advantage members. Programs focus on aligning cardiologists, care teams, and payers around shared quality and outcome goals.
• AscertaincoreTechnology or Integration · 14 January 2026Partnership brings agentic AI automation for prior authorizations across CVAUSA's network of 460+ physicians serving 1.3 million patients. Part of broader technology integration strategy.
• HybridChartcoreTechnology or Integration · 3 June 2025HybridChart selected as preferred mobile rounding and data solutions provider for CVAUSA. The partnership streamlines workflow efficiencies for cardiologists while rounding at hospitals by capturing critical patient data, charge data, and discharge planning information through a centralized, standardized data platform.
• CliniicoreTechnology or Integration · 28 January 2025Clinii selected as preferred platform for virtual care management across CVAUSA practices. Partnership taps into Clinii's AI-driven capabilities to elevate quality of care for patients, aligning with CVAUSA's shift towards value-based healthcare.
• ROMTechcoreTechnology or Integration · 12 November 2024Multi-year strategic partnership with ROMTech to deliver home-based cardiac rehabilitation services using ROMTech's proprietary PortableConnect system. The system enables clinician-controlled cardiac rehabilitation sessions remotely to patients in their homes.
• Prospect Health Services / CharterCare Provider GroupcoreStrategic or Co-development Partner · 15 October 2024Innovative value-based care partnership with Prospect Medical Holdings to improve care for cardiovascular disease patients across Rhode Island. Initial focus on Medicare Advantage plans jointly cared for by Prospect and Cardiovascular Institute of New England (CVAUSA partner group).
• InnovaCare HealthcoreStrategic or Co-development Partner · 6 October 2023First-of-its-kind value-based care alliance with InnovaCare Health focusing on patients in Northeast Florida jointly cared for by Family Care Partners (primary care) and First Coast Heart and Vascular (CVAUSA partner). Partnership aims to improve care quality and reduce total costs through proactive management of chronic cardiovascular diseases.
• MedAxiomcoreStrategic or Co-development Partner · 3 October 2023Strategic partnership with MedAxiom, the cardiovascular community's premier source for organizational performance solutions. All CVAUSA groups who are not currently MedAxiom members will join MedAxiom. The partnership demonstrates CVAUSA's commitment to building the leading cardiovascular care network and educates members about private equity in cardiovascular space.

Scale indicators20 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Gastro Health: PE-sponsored (Olympus Partners, later AmSurg) platform that consolidates independent gastroenterology practices — same multi-state specialty MSO playbook with ASC co-development and value-based contracting focus as CVAUSA's cardiology platform.
• EyeCare Partners: PE-backed (Partners Group) national ophthalmology and optometry practice management platform providing growth capital and administrative services to independent eye-care practices — comparable specialty MSO roll-up strategy in another physician-dominated specialty.
• Shields Health Solutions: PE-backed (Welsh, Carson, Anderson & Stowe) specialty pharmacy and care platform embedded in health systems — adjacent specialty enablement model with similar payer-aligned, value-based orientation and PE sponsorship profile.
• OneOncology: PE-sponsored (TPG) national platform that partners with independent oncology practices to provide capital, technology, and value-based care enablement — the closest specialty-by-specialty analog to CVAUSA's cardiology-focused physician practice management model.
• Panoramic Health: PE-backed (General Atlantic) nephrology-focused physician practice platform partnering with independent kidney-care specialists on value-based contracts — analogous specialty roll-up with strong emphasis on VBC contracting, similar in spirit to CVAUSA's Novocardia division.
• US Anesthesia Partners: PE-backed (Berkshire Partners) specialty physician practice management platform consolidating independent anesthesiology groups — directly comparable operating model to CVAUSA's roll-up of independent cardiology practices with capital and administrative support. US Anesthesia Partners was one of the targets of recent FTC action against PE healthcare roll-ups, a relevant precedent for CVAUSA.

Broad incumbents

• Privia Health Group: Public physician enablement company providing technology, analytics, and practice management to multi-specialty groups — broader incumbent offering similar capital-light physician practice services, including for cardiology groups, with deeper payer relationships but less cardiology-specific specialization.
• agilon health: Public value-based care platform partnering with primary care physicians on full-risk Medicare Advantage contracts — comparable VBC economics and aging-population focus, though agilon operates predominantly in primary care rather than cardiology specialty.

Others

• MedAxiom: Cardiovascular community membership organization and performance solutions provider — explicitly a CVAUSA strategic partner, providing CV-specific operational benchmarks and educational content to CVAUSA's partner practices, more vendor/enabler than competitor.

Emerging players

• Solaris Health: PE-backed urology specialty platform consolidating independent urology practices — another specialty physician practice MSO following the same template of capital infusion + administrative support + ASC co-development as CVAUSA, smaller in scale.

Market position

Strengths1 record

Weaknesses5 records

Competitive moat6 records

Key risks1 record

Key highlights8 records

Customer concentration

• Facebookfacebook.com/CardiovascularAssociatesofAmerica
• Instagraminstagram.com/heartvascularaz
• Xx.com/CardiovUSA
• LinkedInlinkedin.com/company/cvausa

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles15 records

Subsidiaries5 records

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cardiovascular Associates of America